SCHEMBL15910890

SCHEMBL15910890

CC(C)(C(=O)OCc1ccccc1)c1ccc(O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.54
▸ ALDH1A1 P00352 4/20 0.51
▸ CA12 O43570 1/20 0.48
▸ AKR1B10 O60218 1/20 0.48
▸ AKR1B1 P15121 1/20 0.48
▸ CA4 P22748 1/20 0.48
▸ CA6 P23280 1/20 0.48
▸ CA5A P35218 1/20 0.48
▸ CA7 P43166 1/20 0.48
▸ CA9 Q16790 1/20 0.48
▸ CA14 Q9ULX7 1/20 0.48
▸ CA5B Q9Y2D0 1/20 0.48
▸ PTPN1 P18031 2/20 0.47
▸ CHRM2 P08172 1/20 0.47
▸ CHRM4 P08173 1/20 0.47
▸ CHRM1 P11229 1/20 0.47
▸ CHRM3 P20309 1/20 0.47
▸ PTPRC P08575 1/20 0.47
▸ TDP1 Q9NUW8 2/20 0.46
▸ SLC6A2 P23975 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3045824 0.88 ALDH1A1 (0.49) ALDH1A1PTPN1PTPRCTDP1SLC6A2
SCHEMBL23876180 0.88 KMT2A (0.50) LMNAALDH1A1PTPN1PTPRCTDP1
SCHEMBL228601 0.88 NR4A2 (0.51) LMNAALDH1A1PTPN1PTPRCTDP1
SCHEMBL23876186 0.88 NPC1 (0.49) LMNAALDH1A1PTPN1PTPRCTDP1
SCHEMBL13313606 0.86 MAOB (0.59) LMNAALDH1A1SLC6A2SLC6A3L3MBTL1
SCHEMBL11625164 0.84 ALDH1A1 (0.49) LMNAALDH1A1PTPN1PTPRCTDP1
SCHEMBL24773109 0.84 POLB (0.52) LMNAALDH1A1PTPN1CHRM2CHRM4
SCHEMBL17472474 0.83 ALDH1A1 (0.47) LMNAALDH1A1CHRM2CHRM4CHRM1
SCHEMBL4679715 0.82 ALDH1A1 (0.46) ALDH1A1PTPN1PTPRCTDP1SLC6A2
SCHEMBL25300422 0.82 PTPN1 (0.46) ALDH1A1PTPN1PTPRCTDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10835520-B2 Phenyl derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2020-11-17 — — US disclosed
US-20190030010-A1 PHENYL DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2019-01-31 — — US disclosed
US-10117861-B2 Phenyl derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2018-11-06 — — US disclosed
EP-3150577-B1 PHENYL DERIVATIVE ONO PHARMACEUTICAL CO (JP) 2018-08-29 — — EP disclosed
CN-105189454-B Phenyl derivatives 小野药品工业株式会社 2018-07-13 — — CN disclosed
EP-2980072-B1 PHENYL DERIVATIVE ONO PHARMACEUTICAL CO (JP) 2018-04-25 — — EP disclosed
US-20180042908-A1 PHENYL DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2018-02-15 — — US disclosed
US-9820980-B2 Phenyl derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2017-11-21 — — US disclosed
US-9676719-B2 Phenyl derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2017-06-13 — — US disclosed
EP-3150577-A1 PHENYL DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2017-04-05 — — EP disclosed
US-20160213660-A1 PHENYL DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2016-07-28 — — US disclosed
US-9340499-B2 Phenyl derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2016-05-17 — — US disclosed
US-20160039757-A1 PHENYL DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2016-02-11 — — US disclosed
EP-2980072-A1 PHENYL DERIVATIVE ONO Pharmaceutical Co., Ltd. (JP) 2016-02-03 — — EP disclosed
CN-105189454-A Phenyl derivative ONO PHARMACEUTICAL CO 2015-12-23 — — CN disclosed
US-20150126486-A1 PHENYL DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2015-05-07 — — US disclosed
US-8975409-B2 Phenyl derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2015-03-10 — — US disclosed
US-20140235611-A1 PHENYL DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2014-08-21 — — US disclosed
EP-2762466-A1 PHENYL DERIVATIVE ONO Pharmaceutical Co., Ltd. (JP) 2014-08-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10117861-B2 Phenyl derivative S1PR2, S1PR1, S1PR3 LMNA 1664/4885ALDH1A1 1254/4885CA12 4824/4885
US-20150126486-A1 PHENYL DERIVATIVE S1PR2, S1PR1, S1PR3 LMNA 1797/4885ALDH1A1 1253/4885CA12 4811/4885
US-20180042908-A1 PHENYL DERIVATIVE S1PR2, S1PR1, S1PR3 LMNA 1664/4885ALDH1A1 1254/4885CA12 4824/4885
US-20190030010-A1 PHENYL DERIVATIVE S1PR2, S1PR1, S1PR3 LMNA 1664/4885ALDH1A1 1254/4885CA12 4824/4885
US-20160213660-A1 PHENYL DERIVATIVE S1PR2, S1PR1, S1PR3 LMNA 1664/4885ALDH1A1 1254/4885CA12 4824/4885
US-20140235611-A1 PHENYL DERIVATIVE S1PR2, S1PR1, S1PR3 LMNA 1797/4885ALDH1A1 1253/4885CA12 4811/4885
US-10835520-B2 Phenyl derivative S1PR2, S1PR1, S1PR3 LMNA 1664/4885ALDH1A1 1254/4885CA12 4824/4885
US-20160039757-A1 PHENYL DERIVATIVE S1PR2, S1PR1, S1PR5 LMNA 2931/4885ALDH1A1 2273/4885CA12 4559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback